http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2505817-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7700b069d7d6864be93bb1b5d9007589 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be492ec3ee506c95b3fb905575c982de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba6c2126d898efa5fbe053bdec261ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd6e455470423e595e70003c6077bcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e9188e130431a50d6f3f1c43670ff3 |
| publicationDate | 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2505817-C1 |
| titleOfInvention | Method for assessing radiosensitivity of airway cancer |
| abstract | FIELD: medicine. n SUBSTANCE: what is found is a pre-therapeutic rate of haemopoietic stem cells with immunophenotype CD34+CD45 low among peripheral lymphocytes at the stages T3 or T4 to be compared to its discrimination level of 6.0×10 -4 . If the value occurs to exceed 6.0×10 -4 , a high radiosensitivity of the tumour is predicted, while the value of 6.0×10 -4 or less enables predicting a low radiosensitivity of the tumour. n EFFECT: using the presented method enables predicting the radiosensitivity of the malignant growths to irradiation for the purpose of indicating for the radiation therapy in the patients with the stage T3 or T4 of airway cancer. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2735982-C2 |
| priorityDate | 2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.